References
- Dinarello CA. 2011. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 117: 3720-3732.
- Rubartelli A, Cozzolino F, Talio M, Sitia R. 1990. A novel secretory pathway for interleukin-1 beta, a protein lacking a signal sequence. EMBO J. 9: 1503-1510.
- Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, et al. 1992. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 356: 768-774.
- Keller M, Ruegg A, Werner S, Beer HD. 2008. Active caspase-1 is a regulator of unconventional protein secretion. Cell 132: 818-831. https://doi.org/10.1016/j.cell.2007.12.040
- Agostini L, Martinon F, Burns K, McDermott MF, Hawkins PN, Tschopp J. 2004. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 20: 319-325. https://doi.org/10.1016/S1074-7613(04)00046-9
- Fernandes-Alnemri T, Yu JW, Datta P, Wu J, Alnemri ES. 2009. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 458: 509-513. https://doi.org/10.1038/nature07710
- Latz E, Xiao TS, Stutz A. 2013. Activation and regulation of the inflammasomes. Nat. Rev. Immunol. 13: 397-411. https://doi.org/10.1038/nri3452
- Yu JW, Lee MS. 2016. Mitochondria and the NLRP3 inflammasome: physiological and pathological relevance. Arch. Pharm. Res. 39: 1503-1518. https://doi.org/10.1007/s12272-016-0827-4
- Haneklaus M, O'Neill LA, Coll RC. 2013. Modulatory mechanisms controlling the NLRP3 inflammasome in inflammation: recent developments. Curr. Opin. Immunol. 25:40-45.
- Ghonime MG, Shamaa OR, Das S, Eldomany RA, Fernandes-Alnemri T, Alnemri ES, et al. 2014. Inflammasome priming by lipopolysaccharide is dependent upon ERK signaling and proteasome function. J. Immunol. 192: 3881-3888. https://doi.org/10.4049/jimmunol.1301974
- Juliana C, Fernandes-Alnemri T, Kang S, Farias A, Qin F, Alnemri ES. 2012. Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation. J. Biol. Chem. 287: 36617-36622. https://doi.org/10.1074/jbc.M112.407130
- Fernandes-Alnemri T, Kang S, Anderson C, Sagara J, Fitzgerald KA, Alnemri ES. 2013. Cutting edge: TLR signaling licenses IRAK1 for rapid activation of the NLRP3 inflammasome. J. Immunol. 191: 3995-3999. https://doi.org/10.4049/jimmunol.1301681
- He Y, Franchi L, Nunez G. 2013. TLR agonists stimulate Nlrp3-dependent IL-1beta production independently of the purinergic P2X7 receptor in dendritic cells and in vivo. J. Immunol. 190: 334-339. https://doi.org/10.4049/jimmunol.1202737
- Hwang I, Yang J, Hong S, Lee EJ, Lee SH, Fernandes-Alnemri T, et al. 2015. Non-transcriptional regulation of NLRP3 inflammasome signaling by IL-4. Immunol. Cell Biol. 93: 591-599. https://doi.org/10.1038/icb.2014.125
- Vigano E, Diamond CE, Spreafico R, Balachander A, Sobota RM, Mortellaro A. 2015. Human caspase-4 and caspase-5 regulate the one-step non-canonical inflammasome activation in monocytes. Nat. Commun. 6: 8761. https://doi.org/10.1038/ncomms9761
- Tateda K, Matsumoto T, Miyazaki S, Yamaguchi K. 1996. Lipopolysaccharide-induced lethality and cytokine production in aged mice. Infect. Immun. 64: 769-774.
- Eltom S, Belvisi MG, Yew-Booth L, Dekkak B, Maher SA, Dubuis ED, et al. 2014. TLR4 activation induces IL-1beta release via an IPAF dependent but caspase 1/11/8 independent pathway in the lung. Respir. Res. 15: 87. https://doi.org/10.1186/s12931-014-0087-0
- Yu JW, Fernandes-Alnemri T, Datta P, Wu J, Juliana C, Solorzano L, et al. 2007. Pyrin activates the ASC pyroptosome in response to engagement by autoinflammatory PSTPIP1 mutants. Mol. Cell 28: 214-227. https://doi.org/10.1016/j.molcel.2007.08.029
- Fernandes-Alnemri T, Wu J, Yu JW, Datta P, Miller B, Jankowski W, et al. 2007. The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation. Cell Death Differ. 14: 1590-1604. https://doi.org/10.1038/sj.cdd.4402194
- Broz P, Dixit VM. 2016. Inflammasomes: mechanism of assembly, regulation and signalling. Nat. Rev. Immunol. 16: 407-420. https://doi.org/10.1038/nri.2016.58
- Mariathasan S, Monack DM. 2007. Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nat. Rev. Immunol. 7: 31-40. https://doi.org/10.1038/nri1997
- Py BF, Kim MS, Vakifahmetoglu-Norberg H, Yuan J. 2013. Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity. Mol. Cell 49: 331-338. https://doi.org/10.1016/j.molcel.2012.11.009
- Kayagaki N, Wong MT, Stowe IB, Ramani SR, Gonzalez LC, Akashi-Takamura S, et al. 2013. Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science 341: 1246-1249.
- Hagar JA, Powell DA, Aachoui Y, Ernst RK, Miao EA. 2013. Cytoplasmic LPS activates caspase-11: implications in TLR4-independent endotoxic shock. Science 341: 1250-1253. https://doi.org/10.1126/science.1240988
- Stammler D, Eigenbrod T, Menz S, Frick JS, Sweet MJ, Shakespear MR, et al. 2015. Inhibition of histone deacetylases permits lipopolysaccharide-mediated secretion of bioactive IL-1beta via a caspase-1-independent mechanism. J. Immunol. 195: 5421-5431. https://doi.org/10.4049/jimmunol.1501195
Cited by
- Role of Muramyl Dipeptide in Lipopolysaccharide-Mediated Biological Activity and Osteoclast Activity vol.2018, pp.None, 2018, https://doi.org/10.1155/2018/8047610
- Pterostilbene Protects Against Lipopolysaccharide/D-Galactosamine-Induced Acute Liver Failure by Upregulating the Nrf2 Pathway and Inhibiting NF- κ B, MAPK, and NLRP3 Inflammasome Activation vol.23, pp.9, 2018, https://doi.org/10.1089/jmf.2019.4647